Clinical Trial Update: HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for HER2-directed CAR-T cells in patients with recurrent brain or leptomeningeal metastases from breast cancer; study is active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer
• Leptomeningeal Metastases

Drugs mentioned

• HER2 CAR-T cells

Snippet

Sponsor: City of Hope Medical Center | Conditions: Malignant Neoplasm, Metastatic Malignant Neoplasm in the Brain | Phase 1 | Status: ACTIVE_NOT_RECRUITING